Therapy Areas: Respiratory
14 November 2018 - - The US Food and Drug Administration has approved Keytruda, US-based pharmaceutical company Merck's (NYSE: MRK) anti-PD-1 therapy, for the treatment of patients with hepatocel...
14 November 2018 - - US-based RNAi-based therapeutics developer Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has presented clinical data from a Phase 1 study of ARO-AAT, the company's second gen...
14 November 2018 - Biopharmaceutical company Modis Therapeutics revealed on Tuesday the receipt of European Medicines Agency (EMA) PRIME (PRIority MEdicines) designation for its investigational MT1621...
14 November 2018 - AstraZeneca Plc (LSE:AZN), a global, science-led biopharmaceutical company, announced on Tuesday an agreement to sell US rights to Synagis (palivizumab), used for the prevention of ...
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to ...
13 November 2018 - - Japanese drugmaker Eisai Co., Ltd. and US-based Merck (NYSE: MRK) have received results from presentations of new data and analyses of Lenvima (lenvatinib), an orally available ki...